Despite the clear evidence of involvement of FGFR2 in breast cancer, and association of polymorphisms in FGFR2 with breast cancer [5,6], the mechanism by which these polymorphisms predispose to breast cancer remains uncertain. The gene discussed is FGFR2; the disease is breast carcinoma.